Search clinical trials for: Enzalutamide Pill
Total 3001 results
-
Andreas JosefssonGöteborg University; Umeå University; Sahlgrenska University Hospital, Sweden; Sundsvall... and other collaboratorsTerminated
-
ESSA PharmaceuticalsRecruitingProstate CancerCanada, United States, Australia
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedProstate Cancer | Pharmacokinetics of EnzalutamideUnited States
-
Guang'anmen Hospital of China Academy of Chinese...Tasly Pharmaceuticals, Inc.Completed
-
Radboud University Medical CenterActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Groupe Hospitalier Pitie-SalpetriereCompletedEpilepsy | Prostate Cancer | Neuropathy | EncephalopathyFrance
-
Translational Research Center for Medical Innovation...Kagawa UniversityCompleted
-
Instituto Nacional de Perinatologia Isidro Espinosa...Completed
-
National Cancer Institute (NCI)Terminated
-
Hinova Pharmaceuticals Inc.CompletedMetastatic Castration Resistant Prostate CancerChina
-
Macquarie University, AustraliaUnknown
-
Fundación Canaria de Investigación SanitariaHospital Universitario de CanariasUnknown
-
European Organisation for Research and Treatment...Bayer; Latin American Cooperative Oncology Group; UNICANCER; Astellas Pharma Europe... and other collaboratorsActive, not recruitingProstate CancerSpain, Belgium, France, Italy, United Kingdom, Denmark, Canada, Ireland, Brazil, Norway, Poland, Switzerland
-
Ricardo Pereira MestreOncology Institute of Southern Switzerland; Institute of Oncology Research; Institute...TerminatedCOVID-19 InfectionSwitzerland
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Completed
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.Medivation, Inc.WithdrawnMetastatic Castration-Resistant Prostate Cancer
-
Alessa Therapeutics Inc.National Cancer Institute (NCI)Not yet recruitingProstate AdenocarcinomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingMetastatic Castrate-resistant Prostate (CRPC) CancerFrance
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Grupo Español de Tumores Huérfanos e InfrecuentesAstellas Pharma Inc; Apices Soluciones S.L.Completed
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedProstate Cancer | Castration Resistant Prostate CancerUnited States
-
Astellas Pharma IncPfizerCompletedCastration-resistant Prostate CancerJapan
-
Case Comprehensive Cancer CenterCompletedAdenocarcinoma of the ProstateUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedKidney Diseases | Healthy Subjects | Pharmacokinetics of MDV3100Moldova, Republic of
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedHealthy Subjects | Relative Bioavailability | Castration Resistant Prostate Cancer (CRPC) | MDV3100Germany
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedHealthy Subjects | Pharmacokinetics of MDV3100Netherlands
-
Syntrix Biosystems, Inc.National Cancer Institute (NCI)RecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Zenith EpigeneticsEnrolling by invitation
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustUnknownAdenocarcinoma of the ProstateUnited Kingdom
-
Weill Medical College of Cornell UniversitySagimet Biosciences Inc.RecruitingProstatic Neoplasms, Castration-ResistantUnited States
-
OHSU Knight Cancer InstituteAstellas Pharma US, Inc.; Oregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
BayerTerminatedProstatic Cancer, Castration-ResistantUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompletedAdvanced Hepatocellular CarcinomaCanada, United States, Hong Kong, Italy, Korea, Republic of, Puerto Rico, Spain, Taiwan, United Kingdom
-
AstraZenecaParexelCompleted
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
University of ChicagoRecruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
Nuvation Bio Inc.WithdrawnProstate Cancer | Prostate Neoplasm | Cancer of the Prostate | Prostatic Cancer | Castrate Resistant Prostate Cancer | Cancer of Prostate | Castration Resistant Prostatic Cancer | Castration Resistant Prostatic NeoplasmsUnited States
-
Kangpu Biopharmaceuticals, Ltd.CompletedCastration-Resistant Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.Active, not recruitingSalivary CancerUnited States
-
Spanish Oncology Genito-Urinary GroupAstellas Pharma Inc; Apices Soluciones S.L.CompletedHormone-refractory Prostate CancerSpain
-
Institute of Cancer Research, United KingdomAstraZeneca; Astellas Pharma Inc; Prostate Cancer UKTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
Memorial Sloan Kettering Cancer CenterMedivation, Inc.CompletedPrimary Peritoneal Carcinoma | Fallopian Tube | Advanced Epithelial Ovarian | Recurrent Epithelial OvarianUnited States
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Progressive Castration-resistant Prostate CancerUnited States